CVS Health Corp (CVS) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 6, 2026.
- Filings shown
- 19
- Open-market buys
- 1
- Open-market sells
- 8
- Buys, 10b5-1 box not checked
- 1 of 1
Counts cover the 19 most recent Form 4 filings Tradune holds for CVS (filed May 11 – Nov 6, 2026); the score below covers only the trailing 90 days (1 buy, 0 sells). SEC EDGAR Form 4 filings for CVS last checked Nov 21, 2026, 09:00 UTC; the latest CVS filing Tradune holds was filed Nov 6, 2026. This is not guaranteed to be the complete record — see CVS's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 1 filing Tradune holds for CVS filed Nov 6, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
| Insider | Buys | Sells | Shares bought | Shares sold | Value |
|---|---|---|---|---|---|
| Prem S. ShahEVP and Group President | 1 | 0 | 23,855 | — | +$2,001,315 |
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Insider-activity score
56/ 100
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at CVS
Insiders reported 1 open-market purchase of CVS between May 11, 2026 and Nov 6, 2026, across 1 distinct buyer. The most recent purchase was reported by Prem S. Shah (EVP and Group President) on Nov 6, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market purchase 10b5-1 box not checked | 23,855 | $83.90 | 88,516 | +37% | Nov 6, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Tax withholding | 454 | $90.98 | 27,606 | −1.6% | Jun 26, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Tax withholding | 2,478 | $90.98 | 3,008 | −45% | May 31, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Tax withholding | 7,618 | $90.98 | 9,557 | −44% | May 31, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Disposition to issuer | 1,563 | $93.50 | 10,513 | −13% | May 21, 2026 |
| Disposition to issuer | 30,437 | $93.78 | 12,076 | −72% | May 20, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Derivative sale Cash-Settled Swaps | 378,000 | $93.31 | — | — | May 21, 2026 |
| Open-market sale 10b5-1 box not checked | 370,462 | $93.45 | 4,824,799 (indirect) | −7.1% | May 21, 2026 |
| Open-market sale 10b5-1 box not checked | 152,691 | $94.81 | 5,262,942 (indirect) | −2.8% | May 20, 2026 |
| Open-market sale 10b5-1 box not checked | 66,881 | $95.67 | 5,196,061 (indirect) | −1.3% | May 20, 2026 |
| Open-market sale 10b5-1 box not checked | 797,628 | $93.48 | 5,415,633 (indirect) | −13% | May 20, 2026 |
| Open-market sale 10b5-1 box not checked | 800 | $96.28 | 5,195,261 (indirect) | −0.0% | May 20, 2026 |
| Open-market sale 10b5-1 box not checked | 1,983,387 | $94.45 | 6,213,412 (indirect) | −24% | May 19, 2026 |
| Open-market sale 10b5-1 box not checked | 151 | $95.18 | 6,213,261 (indirect) | −0.0% | May 19, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Deferred Stock Units | 1,448 | $97.15 | — | — | May 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Deferred Stock Units | 1,737 | $97.15 | — | — | May 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 1,563 | $97.15 | 42,513 | +3.8% | May 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 2,058 | $97.15 | 15,717 | +15% | May 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 1,447 | $97.15 | 14,434 | +11% | May 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 1,447 | $97.15 | 7,376 | +24% | May 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 1,447 | $97.15 | 15,106 | +11% | May 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Deferred Stock Units | 1,448 | $97.15 | — | — | May 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Deferred Stock Units | 1,544 | $97.15 | — | — | May 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 1,544 | $97.15 | 129,316 | +1.2% | May 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Deferred Stock Units | 1,448 | $97.15 | — | — | May 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Deferred Stock Units | 1,930 | $97.15 | — | — | May 14, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 69,551 | $89.58 | 10,133 | −87% | May 8, 2026 |
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to CVS's (Nov 6, 2026).
Frequently asked about CVS insider activity
How many insiders bought CVS stock in these Form 4 filings?
1 distinct insider at CVS Health Corp reported 1 open-market purchase (Form 4 code P) of CVS shares between May 11, 2026 and Nov 6, 2026, the most recent filed by Prem S. Shah (EVP and Group President) on Nov 6, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Who filed the most recent Form 4 for CVS?
The most recent Form 4 on this page was filed by Prem S. Shah (EVP and Group President) on Nov 6, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market CVS insider sale shown?
The largest open-market sale among the filings shown was 1,983,387 CVS shares at $94.45 (about $187,326,935) by Larry Robbins (Director) on May 19, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.
Do the recent CVS insider purchases have the Form 4 10b5-1 box checked?
No. The one CVS open-market purchase shown was reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Prem S. Shah (EVP and Group President) on Nov 6, 2026, 23,855 shares.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for CVS — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.